Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03320226 · ClinicalTrials.gov registry record · NA
A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy
A NA study of Pregnancy Early and Nausea Gravidarum, sponsored by University of California, Davis.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
- 1
- Study location
NCT03320226: Completed NA study of Pregnancy Early and Nausea Gravidarum, sponsored by University of California, Davis.
NCT03320226 is a NA study of Pregnancy Early and Nausea Gravidarum that has completed, run by University of California, Davis. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03320226, a NA study of Pregnancy Early and Nausea Gravidarum, has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose as well as the aim of this project is to understand the effect of probiotics on gastrointestinal (GI) dysfunction such as nausea, vomiting, and constipation that are found during the first and second trimesters of pregnancy. The primary objective of this project is to uncover whether probiotics have an effect on GI functional disorders. The secondary objective is to identify the microbiota associated with probiotic intake. The tested hypothesis is that gut microbiota influences the GI functions and may influence constipation, nausea, and vomiting during pregnancy.
Primary Outcome
Using scale of 1-5, quantify the seriousness of sick to the stomach, dry heaves, fatigue, lack of energy, and feeling blue.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Probiotic 10 (Nature's Bounty)
Study Locations (1)
California
- University of California, Davis - Sacramento
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2021-04-02 |
| Phase | NA |
What the finished NCT03320226 record still lists
NCT03320226 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 3 conditions, with Pregnancy Early appearing as the primary indexed condition, and to 1 intervention - of which Probiotic 10 (Nature's Bounty) is the first listed.
NCT03320226 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03320226 about?
NCT03320226 is a clinical study titled "A Study of the Effect of Probiotics on Gastrointestinal Function During Pregnancy". The purpose as well as the aim of this project is to understand the effect of probiotics on gastrointestinal (GI) dysfunction such as nausea, vomiting, and constipation that are found during the first and second trimesters of pregnancy. The primary objective of this project is to uncover whether pr...
What is the current status of trial NCT03320226?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2018-01-09. Estimated completion is 2021-04-02.
What conditions does trial NCT03320226 study?
This clinical trial studies the following conditions: Pregnancy Early, Nausea Gravidarum, Vomiting of Pregnancy.
What interventions are being tested in trial NCT03320226?
The interventions under investigation include: Probiotic 10 (Nature's Bounty) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT03320226?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03320226 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy Early
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03320226's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI